http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Game On! Nex Playground Partners With National Hockey League to Launch First-Ever Sports League Title - NHL Puck Rush
-
EXPLR and The News Movement Launch Science Communication Program to Empower the Next Generation of Storytellers
-
n-Lorem Foundation Organizes Third Annual Nano-rare Patient Colloquium, Highlighting Scientific and Clinical Advancements Achieved Since Organization’s Founding
-
Domaine Carneros Unveils its 2025 Holiday Gift Collection
-
Lil Jon Stars in Hyundai's "I See You" Ad Celebrating Culture and Style in the All-New 2026 Palisade Hybrid
-
Saint-Gobain North America Launches “Sustaining Futures, Raising Communities” Program to Build Manufacturing Workforce of Tomorrow
-
Aladdin Wealth™ Launches AI-Enabled Commentary Tool for Wealth Advisors; Morgan Stanley’s Portfolio Risk Platform First to Implement
-
Celebrate Togetherness as Sanrio's Hello Kitty and Friends Reunite in Toca Boca™ World
-
Capstone Green Energy Secures Order from Valparaiso Community Schools for High-Efficiency CHP Systems
-
Mitsubishi Tanabe Pharma America to Present Eight ALS Research Posters at 2025 NEALS Annual Meeting
-
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22
-
Appian Named a Leader in Digital Process Automation Software Report by Independent Research Firm
-
eHealth Earns 2025-26 Great Place To Work Certification™, Recognizing the Company's Strong Culture for the Second Year
-
Kaplan Unveils its First-Ever Real Estate Survey of Trends: Insights on Market Shifts, Client Expectations, and AI’s Impact
-
ReElement Technologies expands rare earth refining capacity at Marion facility
-
SproutGigs Launches Affordable Social Media Growth Services Revolutionizing Digital Marketing for Businesses of All Sizes
-
ReElement Technologies Provides Update on Significant Expansion of Rare Earth and Critical Mineral Refining Capacity at Marion Supersite
-
RAAC Adds $200M of Gold to DeFi with Listed Tokenizer I-ON
-
Digital Underground Co-Founder Chopmaster J and Son, S.O.T.U. Announce New Era of Digital Underground Featuring DUNxG Releases on Intercept Music
-
Ainos reclassified to technology sector under GICS standards
-
ESGold secures C$9 million facility with Ocean Partners
-
ESGold Secures C$9 Million Strategic Partnership with Ocean Partners as Montauban Progress Accelerates
-
ESGold Secures C$9 Million Strategic Partnership with Ocean Partners as Montauban Progress Accelerates
-
Why the Billion Dollar Rare Earth Elements (REE) Market is Projected for Substantial Expansion in Coming Years
-
Ainos Announces GICS Reclassification to Information Technology Sector
-
Ecolomondo’s Hawkesbury TDP Facility Reports Record Monthly Revenues for September
-
Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775
-
UroGen publishes clinical review of ZUSDURI for bladder cancer treatment
-
Sokoman Minerals adds director, grants 6 million stock options
-
VERSES AI names former AWS executive David Scott to board
-
Sokoman Minerals Appoints New Director, Grants Options
-
AbbVie to Host Third-Quarter 2025 Earnings Conference Call
-
VERSES® Welcomes Former Amazon Web Services (AWS) Executive David T. Scott to Board
-
Calico Life Sciences Announces U.S. FDA Fast Track Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
-
FG Nexus and Securitize Enter into Agreement to Natively Tokenize FG Nexus Public Shares on Ethereum
-
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
-
Anavex Life Sciences develops once-daily tablet for ANAVEX3-71 drug
-
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
-
Anavex reports positive phase 2 schizophrenia study results
-
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
-
Bombardier’s Global 7500 Jet Soars to New Heights With its 150th Speed Record, Building on its Industry-Defining Record-Setting Performance
-
Five Monkeys Rescued from Notorious Oregon Roadside Zoo Get a New Start at the Born Free USA Primate Sanctuary in Texas
-
CytoMed Therapeutics publishes research on cancer cell therapy
-
Q2 Metals names Gaivin VP of ESG, Cisco project finalist for award
-
Popeyes® accelerates growth in Mexico through strategic local partnerships
-
Erdene Announces Updated Resource for the Zuun Mod Molybdenum-Copper Deposit
-
Q2 Metals Appoints Simon Gaivin as Vice President - ESG, Cisco Lithium Project Named as Finalist for Discovery of the Year by AEMQ
-
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Le
-
Alchemy Pay Invests in and Forms Exclusive Strategic Cooperation with MiCA-Licensed ZBX Group in the EU
-
First Foundation Inc. Announces Third Quarter 2025 Earnings Conference Call Details
